Cryptosporidiosis should be designated as a tropical disease by the US Food and Drug Administration.
作者信息
Choy Robert K M, Huston Christopher D
机构信息
PATH, San Francisco, California, United States of America.
University of Vermont Larner College of Medicine, Burlington, Vermont, United States of America.
出版信息
PLoS Negl Trop Dis. 2020 Jul 2;14(7):e0008252. doi: 10.1371/journal.pntd.0008252. eCollection 2020 Jul.
Abstract
摘要
相似文献
1
Cryptosporidiosis should be designated as a tropical disease by the US Food and Drug Administration.美国食品药品监督管理局应将隐孢子虫病指定为一种热带疾病。
PLoS Negl Trop Dis. 2020 Jul 2;14(7):e0008252. doi: 10.1371/journal.pntd.0008252. eCollection 2020 Jul.
2
NTZ submitted to FDA for cryptosporidiosis. Food and Drug Administration.硝唑尼特已提交给美国食品药品监督管理局用于治疗隐孢子虫病。美国食品药品监督管理局。
AIDS Treat News. 1998 Feb 6(No 288):5.
3
Orphan drug designation for NTZ expanded.NTZ的孤儿药指定范围扩大。
AIDS Patient Care STDS. 1997 Jun;11(3):198.
4
5
NTZ: advisory committee votes against approval.硝唑尼特：咨询委员会投票反对批准。
AIDS Treat News. 1998 May 15(No 295):7.
6
The Tropical Disease Priority Review Voucher: A Game-Changer for Tropical Disease Products.热带病优先审评券：热带病产品的变革者。
Am J Trop Med Hyg. 2017 Jan 11;96(1):11-13. doi: 10.4269/ajtmh.16-0099. Epub 2016 Aug 29.
7
Is the priority review voucher program stimulating new drug development for tropical diseases?优先审评券计划是否刺激了热带病新药的开发？
PLoS Negl Trop Dis. 2018 Aug 9;12(8):e0006695. doi: 10.1371/journal.pntd.0006695. eCollection 2018 Aug.
8
Another failed promise? NTZ gets the nix.又一个落空的承诺？奈他唑胺被禁用。
J Int Assoc Physicians AIDS Care. 1998 Aug;4(8):26-7, 29.
9
NTZ qualifies for orphan drug status.NTZ 符合孤儿药资格认定。
Posit Aware. 1996 May-Jun;7(3):6.
10
Drug development for neglected diseases - the trouble with FDA review vouchers.被忽视疾病的药物研发——美国食品药品监督管理局审评券的问题
N Engl J Med. 2008 Nov 6;359(19):1981-3. doi: 10.1056/NEJMp0806684.
引用本文的文献
1
Policy and Executive Barriers in Preventing and Eradicating Neglected Tropical Diseases: A Systematic Review.预防和根除被忽视热带病中的政策与执行障碍：一项系统综述
Int J Prev Med. 2024 Oct 18;15:49. doi: 10.4103/ijpvm.ijpvm_251_23. eCollection 2024.
2
Safe and effective treatments are needed for cryptosporidiosis, a truly neglected tropical disease.隐孢子虫病是一种确实被忽视的热带疾病，需要有安全有效的治疗方法。
BMJ Glob Health. 2023 Aug;8(8). doi: 10.1136/bmjgh-2023-012540.
3
The role of atypical MAP kinase 4 in the host interaction with Cryptosporidium parvum.非典型 MAP 激酶 4 在宿主与微小隐孢子虫相互作用中的作用。
Sci Rep. 2023 Jan 19;13(1):1096. doi: 10.1038/s41598-023-28269-w.
4
A comparison of risk factors for cryptosporidiosis and non-cryptosporidiosis diarrhoea: A case-case-control study in Ethiopian children.隐孢子虫病与非隐孢子虫病腹泻危险因素的比较：埃塞俄比亚儿童的病例对照研究。
PLoS Negl Trop Dis. 2022 Jun 6;16(6):e0010508. doi: 10.1371/journal.pntd.0010508. eCollection 2022 Jun.
5
Live imaging of the Cryptosporidium parvum life cycle reveals direct development of male and female gametes from type I meronts.实时观察微小隐孢子虫生活史揭示了 I 型裂殖体直接发育为雌雄配子。
PLoS Biol. 2022 Apr 18;20(4):e3001604. doi: 10.1371/journal.pbio.3001604. eCollection 2022 Apr.
6
The enteric pathogen exports proteins into the cytosol of the infected host cell.肠病原体将蛋白输出到感染宿主细胞的细胞质中。
Elife. 2021 Dec 6;10:e70451. doi: 10.7554/eLife.70451.
7
Cryptosporidium rhoptry effector protein ROP1 injected during invasion targets the host cytoskeletal modulator LMO7.入侵过程中注入的隐孢子虫 rhoptry 效应蛋白 ROP1 靶向宿主细胞骨架调节剂 LMO7。
Cell Host Microbe. 2021 Sep 8;29(9):1407-1420.e5. doi: 10.1016/j.chom.2021.07.002. Epub 2021 Aug 3.
8
Global Goat! Is the Expanding Goat Population an Important Reservoir of ?全球山羊！不断增长的山羊数量是……的重要宿主吗？ （原句似乎不完整）
Front Vet Sci. 2021 Mar 5;8:648500. doi: 10.3389/fvets.2021.648500. eCollection 2021.
9
Use-case scenarios for an anti-Cryptosporidium therapeutic.抗隐孢子虫治疗的应用场景。
PLoS Negl Trop Dis. 2021 Mar 11;15(3):e0009057. doi: 10.1371/journal.pntd.0009057. eCollection 2021 Mar.
本文引用的文献
1
Diarrhoeal disease and subsequent risk of death in infants and children residing in low-income and middle-income countries: analysis of the GEMS case-control study and 12-month GEMS-1A follow-on study.中低收入国家婴幼儿腹泻病及其后续死亡风险：GEMS 病例对照研究和 12 个月 GEMS-1A 随访研究分析。
Lancet Glob Health. 2020 Feb;8(2):e204-e214. doi: 10.1016/S2214-109X(19)30541-8. Epub 2019 Dec 18.
2
Metal-captured inhibition of pre-mRNA processing activity by CPSF3 controls infection.金属捕获抑制 pre-mRNA 加工活性的 CPSF3 控制 感染。
Sci Transl Med. 2019 Nov 6;11(517). doi: 10.1126/scitranslmed.aax7161.
3
The Development Process for Discovery and Clinical Advancement of Modern Antimalarials.现代抗疟药物的发现和临床推进的发展过程。
J Med Chem. 2019 Dec 12;62(23):10526-10562. doi: 10.1021/acs.jmedchem.9b00761. Epub 2019 Aug 20.
4
Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosis.鉴定一种用于治疗隐孢子虫病的强效苯并硼唑类药物候选物。
Nat Commun. 2019 Jun 27;10(1):2816. doi: 10.1038/s41467-019-10687-y.
5
Cryptosporidiosis Outbreaks - United States, 2009-2017.隐孢子虫病疫情爆发 - 美国，2009-2017 年。
MMWR Morb Mortal Wkly Rep. 2019 Jun 28;68(25):568-572. doi: 10.15585/mmwr.mm6825a3.
6
Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis.赖氨酸 tRNA 合成酶作为疟疾和隐孢子虫病的药物靶点。
Proc Natl Acad Sci U S A. 2019 Apr 2;116(14):7015-7020. doi: 10.1073/pnas.1814685116. Epub 2019 Mar 20.
7
Piperazine-Derivative MMV665917: An Effective Drug in the Diarrheic Piglet Model of Cryptosporidium hominis.哌嗪衍生物 MMV665917：隐孢子虫腹泻仔猪模型中的有效药物。
J Infect Dis. 2019 Jun 19;220(2):285-293. doi: 10.1093/infdis/jiz105.
8
Development of 5-Aminopyrazole-4-carboxamide-based Bumped-Kinase Inhibitors for Cryptosporidiosis Therapy.基于 5-氨基吡唑-4-甲酰胺的 bumped-kinase 抑制剂的开发用于隐孢子虫病的治疗。
J Med Chem. 2019 Mar 28;62(6):3135-3146. doi: 10.1021/acs.jmedchem.9b00069. Epub 2019 Mar 15.
9
Optimization of Methionyl tRNA-Synthetase Inhibitors for Treatment of Infection.优化甲硫氨酰-tRNA 合成酶抑制剂以治疗感染。
Antimicrob Agents Chemother. 2019 Mar 27;63(4). doi: 10.1128/AAC.02061-18. Print 2019 Apr.
10
Creative use of the priority review voucher by public and not-for-profit actors delivers the first new FDA-approved treatment for river blindness in 20 years.公共部门和非营利行为体对优先审评券的创造性使用带来了20年来首个获美国食品药品监督管理局批准的治疗河盲症的新药。
PLoS Negl Trop Dis. 2018 Nov 15;12(11):e0006837. doi: 10.1371/journal.pntd.0006837. eCollection 2018 Nov.
Zotero 插件